<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Robotic-Biomanufacturing-Cell-Line on 生物经济</title><link>https://cn.bioecon.ru/technologies/robotic-biomanufacturing-cell-line/</link><description>Recent content in Robotic-Biomanufacturing-Cell-Line on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Wed, 19 Aug 2026 15:43:34 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/technologies/robotic-biomanufacturing-cell-line/index.xml" rel="self" type="application/rss+xml"/><item><title>自动化细胞培养系统</title><link>https://cn.bioecon.ru/technology/automated-cell-culture-systems/</link><pubDate>Wed, 19 Aug 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/automated-cell-culture-systems/</guid><description>自动化细胞与基因治疗背后封闭式、符合GMP要求的细胞培养与生产环节的机器人及软件平台——端到端自动化生产平台、机器人化药品处理，以及协调多仪器自动化工作流程的调度/编排软件——由四家专业公司（Cellares、Multiply Labs、Ori Biotech、HighRes Biosolutions）提供，针对的是劳动密集、易产生偏差的人工细胞治疗生产流程。</description></item></channel></rss>